Koers Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
Aandelen
688266
CNE100003RP1
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
53,36 CNY | -1,97% | +0,79% | +0,79% |
Omzet 2023 | 386 mln. 53,48 mln. 49,56 mln. | Omzet 2024 * | 1,02 mld. 141 mln. 130 mln. | Marktkapitalisatie | 14,12 mld. 1,95 mld. 1,81 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -279 mln. -38,61 mln. -35,78 mln. | Nettowinst (verlies) 2024 * | -139 mln. -19,24 mln. -17,83 mln. | EV/omzet 2023 | 36,3 x |
Nettoliquiditeiten 2023 * | - 0 0 | Nettoliquiditeiten 2024 * | - 0 0 | EV/omzet 2024 * | 13,9 x |
K/w-verhouding 2023 |
-48,6
x | K/w-verhouding 2024 * |
-101
x | Werknemers | 843 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 54,97% |
1 dag | -1,97% | ||
1 week | +0,79% | ||
Lopende maand | +16,91% | ||
1 maand | +15,57% | ||
3 maanden | +6,44% | ||
6 maanden | +15,50% | ||
Lopend jaar | +0,79% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hui Ping Lu
FOU | Founder | 57 | 18-03-09 |
Ze Lin Sheng
CEO | Chief Executive Officer | 64 | 18-03-09 |
Gang Huang
DFI | Director of Finance/CFO | 53 | 01-01-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bing Hui Zhang
BRD | Director/Board Member | 61 | - |
Fan Zhi Huang
BRD | Director/Board Member | 57 | 19-05-22 |
Ze Lin Sheng
CEO | Chief Executive Officer | 64 | 18-03-09 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 36 M€ | +4,92% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 53,36 | -1,97% | 2 543 534 |
27-03-24 | 54,43 | +3,60% | 4 610 130 |
26-03-24 | 52,54 | +1,98% | 1 950 774 |
25-03-24 | 51,52 | +1,42% | 2 853 817 |
22-03-24 | 50,8 | -1,30% | 2 108 460 |
slotkoers Shanghai S.E., 28 maart 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,79% | 1,99 mld. | |
+33,46% | 701 mld. | |
+26,24% | 571 mld. | |
+0,93% | 381 mld. | |
+21,03% | 334 mld. | |
+17,51% | 319 mld. | |
+0,74% | 210 mld. | |
+2,95% | 210 mld. | |
-6,05% | 201 mld. | |
-3,61% | 157 mld. |